Glucuronidasa

Glucuronidasa, commonly referred to as beta-glucuronidase (EC 3.2.1.31), is a hydrolase enzyme that catalyzes the hydrolysis of β-D-glucuronides to yield an aglycone and D-glucuronate. It acts on a wide range of glucuronide substrates, including metabolites, drugs, and xenobiotics that have been conjugated with glucuronic acid for detoxification and solubility.

In humans, beta-glucuronidase is primarily a lysosomal enzyme encoded by the GUSB gene. It is widely distributed, with activity in many tissues, reflecting a role in the intracellular degradation of glycosaminoglycans and other glucuronide conjugates. In the gut, microbial glucuronidases produced by bacteria can deconjugate host and dietary glucuronides, influencing enterohepatic recycling of bile acids and the reactivation of drug metabolites.

Physiological and clinical significance include the breakdown of glucuronides formed during phase II metabolism, a step important for cellular turnover and homeostasis. Deficiency of beta-glucuronidase causes mucopolysaccharidosis type VII (Sly syndrome), a lysosomal storage disorder characterized by accumulation of glycosaminoglycans and multisystemic symptoms. Conversely, microbial glucuronidases can impact drug disposition and toxicity, for example by reactivating certain compounds in the intestine; this has driven research into inhibitors to mitigate adverse effects of some chemotherapeutic regimens.

In summary, glucuronidasa/beta-glucuronidase is a conserved hydrolase involved in glucuronide bond cleavage, with vital roles in metabolism, lysosomal function, and gut microbial interactions, and with notable clinical relevance when its activity is altered.